In the present study, the oral treatment of DEN/PB-supplemented rats with MFP declined the increased levels of these serum tumor markers and the expression of GST-P, thus the MFP possesses potent anticancer activities against DEN/PB-induced HCC. The gene discussed is GSTP1; the disease is neoplasm.